REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Ulivaccines, Inc. (Philippines)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Ulivaccines, Inc. Profile Updated: December 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Ulivaccines, Inc. is a company in Philippines, with a head office in City Of Pasig. It operates in the Pharmaceutical Preparation Manufacturing industry. It was established on November 24, 2008. From the latest financial highlights, Ulivaccines, Inc. reported a net sales revenue drop of 32.47% in 2023. Its total assets decreased by 88.73% over the same period.

Headquarters
4Th Floor Karina Bldg., 33 Shaw Blvd.
City Of Pasig; Second District, National Capital Region (Ncr);

Contact Details: Purchase the Ulivaccines, Inc. report to view the information.

Basic Information
Financial Auditors:
Purchase the Ulivaccines, Inc. report to view the information.
Incorporation Date:
November 24, 2008
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Ulivaccines, Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PHP. Absolute financial data is included in the purchased report.
Net sales revenue
-32.47%▼
Total operating revenue
-32.47%▼
Operating profit (EBIT)
N/A
EBITDA
1839.08%▲
Net Profit (Loss) for the Period
N/A
Total Assets
-88.73%▼
Total Equity
-10.28%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.29%▼
Cash Ratio
-0.21%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo